000			01843 a2200493 4500
005			20250517054008.0
264		0	_c20161230
008			201612s 0 0 eng d
022			_a1873-2402
024	7		_a10.1016/j.biopsych.2015.08.018 _2doi
040			_aNLM _beng _cNLM
100	1		_aPatrizi, Annarita
245	0	0	_aChronic Administration of the N-Methyl-D-Aspartate Receptor Antagonist Ketamine Improves Rett Syndrome Phenotype. _h[electronic resource]
260			_bBiological psychiatry _cMay 2016
300			_a755-764 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aDisease Models, Animal
650	0	4	_aGABAergic Neurons _xdrug effects
650	0	4	_aKetamine _xadministration & dosage
650	0	4	_aMethyl-CpG-Binding Protein 2 _xgenetics
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMice, Knockout
650	0	4	_aNeurons _xdrug effects
650	0	4	_aParvalbumins _xmetabolism
650	0	4	_aPhenotype
650	0	4	_aPhotic Stimulation
650	0	4	_aPyramidal Cells _xdrug effects
650	0	4	_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors
650	0	4	_aRespiration _xdrug effects
650	0	4	_aRett Syndrome _xdrug therapy
650	0	4	_aSurvival Analysis
650	0	4	_aVisual Acuity _xdrug effects
650	0	4	_aVisual Cortex _xdrug effects
700	1		_aPicard, Nathalie
700	1		_aSimon, Alex Joseph
700	1		_aGunner, Georgia
700	1		_aCentofante, Eleonora
700	1		_aAndrews, Nick Arthur
700	1		_aFagiolini, Michela
773	0		_tBiological psychiatry _gvol. 79 _gno. 9 _gp. 755-764
856	4	0	_uhttps://doi.org/10.1016/j.biopsych.2015.08.018 _zAvailable from publisher's website
999			_c25299536 _d25299536